Physician
Psychiatry
Dr. Christopher C. Rowe, MD
|
|
Give Review
Christopher Rowe is an expert in the field of Psychiatry. He went to medical school at University Hospital - University of Cincinnati College of Medicine. Christopher Rowe is a published doctor and has 99 publications published. The lastest was: 'SPECT brain imaging in epilepsy: a meta-analysis.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- The centiloid project: Standardizing quantitative amyloid plaque estimation by PET.
- Differential Diagnosis in Alzheimer's Disease and Dementia with Lewy Bodies via VMAT2 and Amyloid Imaging.
- Cortical surface mapping using topology correction, partial flattening and 3D shape context-based non-rigid registration for use in quantifying atrophy in Alzheimer's ...
- SNM Practice Guideline for Dopamine Transporter Imaging with 123I-Ioflupane SPECT 1.0.
- Brain Amyloid Imaging.
- Subtypes of progressive aphasia: application of the international consensus criteria and validation using {beta}-amyloid imaging.
- Amyloid Imaging with 18F-Florbetaben in Alzheimer Disease and Other Dementias.
- In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer disease.
- Investigation of Matrix Metalloproteinases, MMP-2 and MMP-9, in Plasma Reveals a Decrease of MMP-2 in Alzheimer's Disease.
- Amyloid imaging.
- Amyloid-β: the seeds of darkness.
- Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic gu...
- Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study.
- Quantitative approaches to amyloid imaging.
- Association of plasma Aß peptides with blood pressure in the elderly.
- Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.
- Cerebral β-amyloid detected by Pittsburgh compound B positron emission topography predisposes to recombinant tissue plasminogen activator-related hemorrhage.
- Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging.
- Blood-borne amyloid-beta dimer correlates with clinical markers of Alzheimer's disease.
- In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with (18)F-AV-133.
- High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types.
- <formula>;{11}</formula>C-PiB PET A<formula>_{Bri}</formula> Imaging in Worster-Drought Syndrome (Familial British Dementia): A Case Report.
- The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies.
- Amyloid imaging in Alzheimer's disease and other dementias.
- Radiation dosimetry of beta-amyloid tracers 11C-PiB and 18F-BAY94-9172.
- Characterization of PiB binding to white matter in Alzheimer disease and other dementias.
- Appearance modeling of 11C PiB PET images: characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy aging.
- The ART of loss: Abeta imaging in the evaluation of Alzheimer's disease and other dementias.
- In vitro characterization of Pittsburgh compound-B binding to Lewy bodies.
- Evaluating atypical dementia syndromes using positron emission tomography with carbon 11 labeled Pittsburgh Compound B.
- Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease.
- Positron emission tomography and epilepsy.
- Inflammation following stroke.
- Positron emission tomography with selected mediastinoscopy compared to routine mediastinoscopy offers cost and clinical outcome benefits for pre-operative staging of n...
- Radiation dose to PET technologists and strategies to lower occupational exposure.
- Homocysteine, Vitamin B12, and Folic Acid Levels in Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Elderly: Baseline Characteristics in Subjects of the Au...
- Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer''s disease.
- Olfactory deficits and amyloid-β burden in Alzheimer's disease, mild cognitive impairment, and healthy aging: a PiB PET study.
- Localization of epileptic foci with postictal single photon emission computed tomography.
- Ictal SPECT using technetium-99m-HMPAO: methods for rapid preparation and optimal deployment of tracer during spontaneous seizures.
- Radioiodinated clioquinol as a biomarker for beta-amyloid: Zn complexes in Alzheimer''s disease.
- Spline based inhomogeneity correction for 11C-PIB PET segmentation using expectation maximization.
- Galantamine-induced improvements in cognitive function are not related to alterations in alpha(4)beta (2) nicotinic receptors in early Alzheimer''s disease as measured...
- Awareness of olfactory deficits in healthy aging, amnestic mild cognitive impairment and Alzheimer''s disease.
- Memory profiling with paired associate learning in Alzheimer's disease, mild cognitive impairment, and healthy aging.
- The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study...
- Fluoro-2-deoxy-D-glucose (FDG)-PET in APOEepsilon4 carriers in the Australian population.
- Episodic memory decline predicts cortical amyloid status in community-dwelling older adults.
- Visual and quantitative analysis of interictal SPECT with technetium-99m-HMPAO in temporal lobe epilepsy.
- Ictal postictal and interictal single-photon emission tomography in the lateralization of temporal lobe epilepsy.
- Reduced posterior cingulate binding of I-123 iodo-dexetimide to muscarinic receptors in mild Alzheimer''s disease.
- Human dosimetry and biodistribution of iodine-123-iododexetimide: a SPECT imaging agent for cholinergic muscarinic neuroreceptors.
- SPECT brain imaging in epilepsy: a meta-analysis.
- MR-less high dimensional spatial normalization of 11C PiB PET images on a population of elderly, mild cognitive impaired and Alzheimer disease patients.
- Relationship between nicotinic receptors and cognitive function in early Alzheimer's disease: a 2-[18F]fluoro-A-85380 PET study.
- Amyloid load in Parkinson''s disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography.
- The relationship between nicotinic receptors and cognitive functioning in healthy aging: An in vivo positron emission tomography (PET) study with 2-[(18)F]fluoro-A-85380.
- Olfactory performance in AD, aMCI, and healthy ageing: a unirhinal approach.
- Rare genetically defined causes of dementia.
- Cerebral microhemorrhage and brain β-amyloid in aging and Alzheimer disease.
- Imaging beta-amyloid burden in aging and dementia.
- 11C-PiB PET studies in typical sporadic Creutzfeldt-Jakob disease.
- Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer''s disease.
- SPECT in the localisation of extratemporal and temporal seizure foci.
- Prolonged interval between sentinel pseudotumoral demyelination and development of primary CNS lymphoma.
- Neurosciences.
- Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging.
- 11C-PIB binding is increased in patients with cerebral amyloid angiopathy-related hemorrhage.
- Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia.
- Effects of anticholinergic drugs on cognitive function in older Australians: results from the AIBL study.
- Postictal switch in blood flow distribution and temporal lobe seizures.
- Patterns of postictal cerebral blood flow in temporal lobe epilepsy: qualitative and quantitative analysis.
- Intracerebral haemorrhage: incidence and use of computed tomography.
- Localization of temporal lobe epileptic foci with iodine-123 iododexetimide cholinergic neuroreceptor single-photon emission computed tomography.
- Neuroscience.
- Simultaneous emission transmission tomography using technetium-99m for both emission and transmission.
- Validation of fully automatic brain SPET to MR co-registration.
- Automated (11)C-PiB standardized uptake value ratio.
- Postictal SPET in epilepsy.
- Cost-effectiveness and accuracy of exercise stress echocardiography in the non-invasive diagnosis of coronary heart disease.
- Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease.
- Predictors of rapid cognitive decline in Alzheimer''s disease: results from the Australian imaging, biomarkers and lifestyle (AIBL) study of ageing.
- Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer''s disease.
- Increasing the predictive accuracy of amyloid-β blood-borne biomarkers in Alzheimer's disease.
- A web-based normative data tool for assessing cognitive performance in healthy older Australians.
- Advances in structural and molecular neuroimaging in Alzheimer''s disease.
- 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer''s disease.
- Addressing population aging and Alzheimer''s disease through the Australian imaging biomarkers and lifestyle study: collaboration with the Alzheimer''s Disease Neuroim...
- In vitro characterisation of BF227 binding to alpha-synuclein/Lewy bodies.
- Larger temporal volume in elderly with high versus low beta-amyloid deposition.
- 11C-PiB PET ABri imaging in Worster-Drought syndrome (familial British dementia): a case report.
- Relationship between atrophy and beta-amyloid deposition in Alzheimer disease.
- Plasma amyloid-beta as a biomarker in Alzheimer''s disease: the AIBL study of aging.
- Quantitative gait analysis in patients with dementia with Lewy bodies and Alzheimer''s disease.
- Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer''s disease.
- Imaging of amyloid beta in Alzheimer''s disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism.
- Simplified quantification of nicotinic receptors with 2[18F]F-A-85380 PET.
- Assessment of the role of FDG PET in the diagnosis and management of children with refractory epilepsy.
Schools
University Of Cincinnati College Of Medicine
University Hospital
Procedures Preformed
- Psychiatric Evaluation
Conditions Treated
- Anxiety
- Bipolar Disorder
- Dissociative, Conversion, and Factitious Disorders
- Major Depressive Disorder
- View All
Doctors Specialties
- Geriatric Psychiatry
- Psychiatry
Accepted Insurances
Education
-
University Hospital - University of Cincinnati College of Medicine -
University of Cincinnati College of Medicine
Drug Facts
| NPI NUMBER | 1407864424 | |
| NPPES Provider LastName | ROWE | |
| NPPES Provider FirstName | CHRISTOPHER | |
| NPPES Provider ZIPCode | 452191704 | |
| NPPES Provider State | OH | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 285.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1407864424 |
| Last Name Of The Provider | ROWE |
| First Name Of The Provider | CHRISTOPHER |
| View All |
Similar Doctors
|
|
Dr. Neil S. Dubin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert Lubow, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Velissarios Karacostas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Noel Free, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ashley Harmon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Renu Kotwal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian J. McConville, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles W. Collins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert G. Rohs, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gina M. Guadagno, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George W. Lackemann, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shakil Mohammed, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian P. Dowling, MD |
|
|
Dr. Babu V. Gupta, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ravinder S. Mann, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mya Sabai, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Stanley M. Kaplan
This Doctor is OpenDoctor Recommended.
|